 | Up a level |
Journal Article
Doerner, T., Schulze-Koops, H., Burmester, G. -R., Iking-Konert, C., Schmalzing, M., Engel, A., Kaestner, P., Kellner, H., Kurthen, R., Krueger, K., Rubbert-Roth, A., Schwenke, H., Peters, M. A. and Tony, H. -P. (2019). Early and late responses in patients with rheumatoid arthritis who were conventional synthetic disease-modifying anti-rheumatic drug inadequate responders and were treated with tocilizumab or switched to rituximab: an open-label phase 3 trial (MIRAI). Clin. Exp. Rheumatol., 37 (6). S. 937 - 946. PISA: CLINICAL & EXPER RHEUMATOLOGY. ISSN 1593-098X
Yis, U., Becker, K., Kurul, S., Uyanik, G., Bayram, E., Haliloglu, G., Polat, I., Ayanoglu, M., Okur, D., Tosun, A., Serdaroglu, G., Yilmaz, S., Topaloglu, H., Anlar, B., Cirak, S. and Engel, A. (2017). Genetic Landscape of congenital myasthenic syndroms from Turkey: novel mutations and clinical insights. Neuromusc. Disord., 27. S. S221 - 1. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 1873-2364